Fund Details
UTI Focussed Equity Fund Series I (2195 Days) Direct Growth
| Risk | Moderately High |
|---|---|
| Min SIP Amount | Not Supported |
| Expense Ratio | 2.35% |
| NAV | ₹15.37 (07 Sep 2020) |
|---|---|
| Fund Started | 04 Sep 2014 |
| Fund Size | ₹100 Cr |
Returns
Comparison
Found nothing so far.
Found nothing so far.
Top Holdings
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Infosys Ltd. | Technology | Equity | 8.8% |
| ICICI Bank Ltd. | Financial | Equity | 6.5% |
| Axis Bank Ltd. | Financial | Equity | 5.2% |
| ITC Ltd. | FMCG | Equity | 4.9% |
| Cipla Ltd. | Healthcare | Equity | 4.9% |
| Eicher Motors Ltd. | Automobile | Equity | 4.3% |
| ICICI Prudential Life Insurance Company Ltd. | Financial | Equity | 4.2% |
| Bharti Airtel Ltd. | Communication | Equity | 4.1% |
| Sun Pharmaceutical Inds. Ltd. | Healthcare | Equity | 3.8% |
| PI Industries Ltd. | Chemicals | Equity | 3.1% |
Fund Managers
UTI Focussed Equity Fund Series I (2195 Days) Direct Growth Details
UTI Focussed Equity Fund Series I (2195 Days) Direct Growth is a Equity Mutual Fund Scheme launched by UTI Mutual Fund. This scheme was made available to investors on 04 Sep 2014. Sachin Trivedi is the Current Fund Manager of UTI Focussed Equity Fund Series I (2195 Days) Direct Growth fund.The fund currently has an Asset Under Management(AUM) of ₹100 Cr and the Latest NAV as of 07 Sep 2020 is ₹15.37.
The UTI Focussed Equity Fund Series I (2195 Days) Direct Growth is rated Moderately High risk.
Investment Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of listed companies. The scheme will without any capitalization bias endeavor to invest in either growth stocks or value stocks or both. The Scheme will normally hold upto 30 stocks in the portfolio.
